Core Viewpoint - The company, Wuhu Berteli Automotive Safety Systems Co., Ltd., is utilizing its own funds to pay for part of the fundraising investment projects and will replace these with raised funds, ensuring compliance with regulatory requirements and maintaining the integrity of the fundraising process [1][6]. Fundraising Overview - The company has issued 28,020,000 convertible bonds with a face value of RMB 100 each, raising a total of RMB 2,802,000,000. After deducting issuance costs of RMB 12,349,094.60, the net amount raised is RMB 2,789,650,905.40 [1][2]. - All raised funds are stored in a special account approved by the board of directors to ensure proper management and protection of investor rights [2]. Investment Project Details - The total amount intended for investment in fundraising projects is capped at RMB 280,200.00 million, with adjustments made based on the actual net amount raised after deducting issuance costs [2][3]. - Specific projects include: - 60 million sets of Electronic Mechanical Brake (EMB) systems with an adjusted investment of RMB 18,821.80 million [3]. - 100 million sets of electronic control chassis brake systems with an adjusted investment of RMB 22,645.00 million [3]. - A project in Mexico for producing 7.2 million lightweight components and 2 million brake calipers, with a total investment of USD 16,500 million, calculated at an exchange rate of 1 USD = 7 RMB [3][4]. Use of Own Funds - The company plans to use its own funds to finance part of the investment project in Mexico due to the need for foreign currency transactions, which cannot be directly handled by the domestic fundraising account [4]. - The process involves borrowing from its own funds to the Mexican subsidiary, which will then use these funds for project payments, followed by a replacement with the raised funds [4][5]. Impact on the Company - The use of own funds for part of the investment does not affect the normal implementation of the investment plan and does not change the direction of the raised funds or harm shareholder interests [5][6]. Approval Process - The board of directors and the supervisory board approved the use of own funds for the investment project at meetings held on August 28, 2025 [5][6]. Sponsor's Verification Opinion - The sponsor, China International Capital Corporation, has verified that the company has followed necessary approval procedures and that the use of own funds does not impact the normal progress of the investment projects [6].

Core Viewpoint - The company is utilizing excess raised funds to replace previously invested self-raised funds for ongoing projects, ensuring compliance with regulatory requirements and maintaining the integrity of fundraising purposes [1][5][7]. Fundraising Overview - The company was approved to issue 40 million shares at a price of RMB 28.82 per share, raising a total of RMB 1,152.8 million, with a net amount of RMB 1,049.66 million after deducting issuance costs. The excess funds raised amounted to RMB 341.66 million [1][2]. Investment Project Details - The total investment for the planned projects is RMB 1,009.62 million, with adjusted investment amounts for specific projects, including the rehabilitation equipment research and exhibition center, which saw its total investment increase from RMB 146.73 million to RMB 228.73 million [2][3]. Use of Excess Funds - The company decided to use RMB 79.12 million of the excess funds for the construction of the rehabilitation medical device industrial park, specifically for the research center and related facilities. This decision was approved in the board meeting held on April 23, 2025 [3][4]. Replacement of Self-raised Funds - The company plans to replace RMB 12.91 million of self-raised funds that were previously invested in the rehabilitation medical device industrial park with the excess funds. This replacement was approved in the board meeting on August 27, 2025 [4][5]. Compliance and Verification - The supervisory board and the accounting firm confirmed that the use of excess funds complies with relevant regulations and does not affect the normal implementation of investment projects. The replacement of funds was verified by the accounting firm, ensuring adherence to regulatory standards [5][7][8].

Core Viewpoint - The company plans to use its own funds to pay for investment projects and will replace these funds with raised capital within six months, ensuring compliance with regulatory requirements and maintaining operational efficiency [1][5][7]. Summary by Sections 1. Basic Situation of Raised Funds - The company raised a total of RMB 649,999,990.52 by issuing 51,505,546 shares at a price of RMB 12.62 per share, with a net amount of RMB 643,574,544.72 after deducting issuance costs [1]. 2. Investment Projects - The raised funds will be allocated to two main projects: - Smart Emergency Command Product Upgrade and Industrialization Project - Next-Generation Smart Emergency Digital Transformation Key Technology Research Project - The total investment for these projects is adjusted to RMB 64,357.45 million [2]. 3. Reasons for Using Own Funds - The company faces challenges in directly using raised funds for certain payments, such as employee salaries, due to regulatory requirements. Therefore, it will use its own funds initially and replace them with raised funds later [3][4]. 4. Specific Process for Fund Replacement - The company will implement a structured process for using its own funds and replacing them with raised funds within six months, ensuring compliance and efficiency in fund management [4][5]. 5. Impact on Company Operations - This approach is expected to enhance fund utilization efficiency, reduce financial costs, and improve overall operational management without affecting the normal implementation of investment projects [5][6]. 6. Approval Procedures - The board of directors and the supervisory board have approved the use of own funds for project payments and the subsequent replacement with raised funds, confirming adherence to regulatory guidelines [6][7]. 7. Independent Financial Advisor Opinion - The independent financial advisor has reviewed the process and found it compliant with relevant regulations, supporting the company's approach to fund management [7][8].

国联民生证券承销保荐有限公司 关于湖北盛天网络技术股份有限公司 使用自有资金支付募投项目部分款项并以 募集资金等额置换的核查意见 国联民生证券承销保荐有限公司（以下简称"保荐机构"，曾用名"华英证 券有限责任公司"）作为湖北盛天网络技术股份有限公司（以下简称"盛天网络" 或"公司"）向特定对象发行股票并在创业板上市的保荐机构，根据《证券发行 上市保荐业务管理办法》 《上市公司募集资金监管规则》《深圳证券交易所创业 板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上 市公司规范运作》等相关规定，对公司使用自有资金支付募投项目部分款项并以 募集资金等额置换事项进行了认真、审慎的核查，核查的具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意湖北盛天网络技术股份有限公司向特 定对象发行股票注册的批复》（证监许可【2021】883 号）同意注册，公司本次 向特定对象发行人民币普通股（A 股）31,665,598 股，每股面值为人民币 1.00 元， 发行价格为人民币 15.36 元/股，募集资金总额 486,383,585.28 元，扣除保荐及承 销费用 10,295,75 ...

Summary of Key Points Core Viewpoint - The company plans to use its own funds to pay for investment projects and subsequently replace these funds with raised capital, ensuring efficient use of resources and compliance with regulatory requirements [1][6]. Group 1: Fundraising Overview - The company raised a total of RMB 973.6 million by issuing 40 million shares at RMB 24.34 per share, with a net amount of RMB 891.425937 million after deducting issuance costs [1]. - The funds were deposited into a special account dedicated to the raised capital, adhering to the principle of dedicated use [1]. Group 2: Investment Project Details - As of June 30, 2025, the company has invested RMB 677.7135 million in various projects, including innovative drug research and brand development [2]. - The total committed investment for the projects remains at RMB 891.4259 million, indicating that the company is on track with its financial commitments [2]. Group 3: Reasons for Using Own Funds - The company encountered operational challenges that necessitated the use of its own funds for project payments, primarily due to banking regulations regarding payroll and the need for efficient fund management [3]. - Using own funds initially allows for better management of project costs and compliance with financial regulations, enhancing operational efficiency [3]. Group 4: Replacement Process - The company intends to replace the funds used from its own resources with raised capital within six months, ensuring that the funds are accounted for as part of the investment project [4]. - The replacement process involves transferring equivalent amounts from the special account to the company's own funds account after necessary approvals [4]. Group 5: Impact on Daily Operations - The use of own funds is expected to optimize payment methods for investment projects, improve fund utilization efficiency, and lower financial costs without affecting the company's normal operations [5]. - The decision aligns with the interests of all shareholders and does not alter the intended use of raised funds [5]. Group 6: Approval Procedures - The board of directors and the supervisory board have both approved the proposal to use own funds for project payments, confirming that the decision complies with relevant regulations [6]. - The approval process followed legal and regulatory requirements, ensuring transparency and accountability in the decision-making process [6].

中信证券股份有限公司 根据中国证券监督管理委员会《关于同意江西江南新材料科技股份有限公司 首次公开发行股票注册的批复》（证监许可〔2024〕1805 号）同意注册，并经上 海证券交易所同意，公司首次公开发行人民币普通股（A 股）3,643.63 万股，每 股面值 1 元，每股发行价格为人民币 10.54 元，募集资金总额为人民币 38,403.86 万元，扣除发行费用人民币 5,296.85 万元后，募集资金净额为 33,107.01 万元。 上述募集资金到位情况已经容诚会计师事务所（特殊普通合伙）验证，并于 2025 年 3 月 14 日出具容诚验字[2025]361Z0009 号《验资报告》。 为规范公司募集资金管理和使用，保护公司及投资者权益，公司设立了相关 募集资金专项账户，对募集资金采用了专户储存管理，公司已与保荐机构及募集 资金存储银行签署了募集资金监管协议。 二、募集资金投资项目情况 根据《江西江南新材料科技股份有限公司首次公开发行股票并在主板上市招 股说明书》披露的募集资金使用计划，公司募投项目情况及募集资金使用计划如 下： | | | 单位：万元 | | --- | --- | --- | ...

容诚专字[2025]361Z0495号 容诚会计师事务所(特殊普通合伙) 关于江西江南新材料科技股份有限公司 以自筹资金预先投入募集资金投资项目 及支付发行费用的鉴证报告 江西江南新材料科技股份有限公司 中国·北京 目 录 序号 内 容 页码 以自筹资金预先投入募集资金投资项目及支付发 行费用鉴证报告 以自筹资金预先投入募集资金投资项目及支付发 行费用专项说明 容诚会计师事务所（特殊普通合伙） 本鉴证报告仅供江南新材公司为用募集资金置换预先已投入募集资金投资项 目及支付发行费用的自筹资金之目的使用，不得用作任何其他目的。我们同意将本 鉴证报告作为江南新材公司用募集资金置换预先已投入募集资金投资项目及支付 发行费用的自筹资金必备的文件，随其他文件一起报送并对外披露。 二、管理层的责任 总所：北京市西城区阜成门外大街 22 号 关于江西江南新材料科技股份有限公司 TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 以自筹资金预先投入募集资金投资项目 及支付发行费用的鉴证报告 容诚专字 ...

Summary of Key Points Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., is utilizing raised funds to replace self-raised funds invested in its fundraising projects, following necessary approvals and regulations [1][5][7]. Group 1: Fundraising Overview - The company completed its initial public offering (IPO) of 64,249,446 shares at a price of 6.70 RMB per share, raising a total of 430,471,288.20 RMB, with a net amount of 384,363,201.32 RMB after deducting issuance costs [1][2]. - The funds have been stored in a dedicated account, and a tripartite supervision agreement has been signed with the sponsor and the bank [2][3]. Group 2: Investment Project Details - The company plans to invest the raised funds in specific projects, with a total investment amount of 31,145.75 million RMB [3][4]. - Adjustments to the investment structure and usage of excess funds have been approved by the shareholders' meeting [3][5]. Group 3: Use of Self-raised Funds - As of June 30, 2025, the company has utilized 8.7146 million RMB of self-raised funds for its projects, with an equivalent amount planned for replacement by the raised funds [5][6]. - The specific projects include medical imaging product development and industrial non-destructive testing system research [6]. Group 4: Approval Process - The board of directors and the supervisory board have approved the use of raised funds to replace self-raised funds, confirming compliance with legal regulations and ensuring no adverse effects on shareholder interests [7]. - The sponsor has verified that the replacement of funds does not alter the intended use of the raised funds or harm shareholder interests [7].

Core Viewpoint - The company, Nanjing Mairande Medical Technology Co., Ltd., is utilizing self-raised funds to pay for investment projects and will subsequently replace these with raised funds in an equivalent amount, ensuring compliance with regulations and maintaining operational efficiency [1][5][7]. Fundraising Overview - The total amount raised from the initial public offering (IPO) was RMB 90,975.85 million, with a net amount of RMB 90,975.85 million after expenses. The share price was set at RMB 40.29 [1]. - The funds are stored in a dedicated special account, and a tripartite supervision agreement has been signed with the sponsor and the commercial bank [2]. Investment Project Details - The total investment for the projects is RMB 7,622.54 million, with RMB 65,000.48 million planned to be funded from the raised funds and RMB 57,377.94 million from self-raised funds [2]. Reasons for Using Self-Raised Funds - The company needed to use self-raised funds initially due to regulatory requirements for employee salary payments and other operational expenses, which could not be processed through the special fund account [3][4]. - This approach aims to enhance the efficiency of fund usage and project implementation [6]. Replacement of Funds - As of the date of the report, the company has replaced a total of RMB 2,122.47 million of self-raised funds with raised funds, covering expenses such as salaries, utilities, and government payments [4][5]. Impact on Operations - The use of self-raised funds for project payments will not affect the normal implementation of investment projects and is designed to improve operational efficiency [6][7]. Review Procedures - The board of directors and the supervisory board have approved the use of self-raised funds and the subsequent replacement with raised funds, confirming that the process complies with relevant regulations [6][7].

Core Viewpoint - Shenzhen Youyou Green Energy Co., Ltd. is utilizing raised funds to replace self-raised funds used for issuing expenses, ensuring compliance with regulatory requirements [1][2]. Fundraising and Financial Details - The company has received approval from the China Securities Regulatory Commission for an initial public offering (IPO) to issue 10.5 million shares at a price of RMB 89.60 per share, aiming to raise a total of RMB 940.8 million [3][4]. - After deducting underwriting and advisory fees totaling RMB 24,197,445, the net amount raised is RMB 916,602,555 [4]. - The intended use of the raised funds includes investments in a charging module production base, headquarters and R&D center construction, and supplementing working capital, with a total planned investment of RMB 70 million [5]. Issued Expenses and Replacement Amount - As of July 31, 2025, the company plans to replace self-raised funds used for issuing expenses amounting to RMB 10,549,180.24 [6]. - The breakdown of the expenses includes IPO intermediary fees of RMB 10,447,169.81 and other issuance registration fees of RMB 102,010.43 [6].